The Closing Conditions Trap: How the Signing-to-Closing Gap Kills Startup Acquisition Deals (and What Founders Must Negotiate Before Signing)

You signed the acquisition agreement. The price is locked. Your board approved the deal. The celebrations have begun. But between the signature page and the wire transfer lies a gauntlet that most founders never see coming — and that kills a meaningful percentage of signed deals before they ever close.

That gauntlet is the set of closing conditions: the contractual obligations that must be satisfied or waived between signing and closing. Regulatory approvals. Third-party consents. Key employee retention agreements. Bring-down certificates. No-MAC certifications. Each one is a gate the deal must pass through, and any one of them can become the reason your signed acquisition never closes.

We have written about the MAC clause trap — how buyers use material adverse change provisions to walk away from signed deals. We have covered deal protection provisions like no-shop clauses that lock you in during the signing-to-closing gap. And we have addressed the buy-side due diligence checklist that founders acquiring other companies must run. But no single post has walked through the full set of closing conditions that must be satisfied between signing and closing — a phase where the deal is most vulnerable to what practitioners call "deal drift."

This guide closes that gap. We walk through each category of closing condition, explain how it can kill your deal, and provide clause-by-clause negotiation strategies that founders must deploy before signing — not after, when leverage has evaporated.

What Are Closing Conditions and Why They Matter

Closing conditions are contractual triggers that must be satisfied or waived before either party is obligated to close the transaction. As standard M&A frameworks explain, each closing condition has an owner, a target date, and a status — and failure of any unwaived condition gives the affected party the right to walk away.

The critical categories include regulatory approvals, third-party consents, bring-down of representations and warranties, no material adverse change (MAC), covenant compliance, key employee retention, and the delivery of officers' certificates and legal opinions. The ABA Model Asset Purchase Agreement and standard merger agreements structure these conditions as prerequisites — not aspirations. If a condition is not met and not waived, the deal does not close.

The signing-to-closing gap can stretch from days to months depending on the deal's complexity. During that window, the business continues to operate, regulatory clocks run, third parties decide whether to consent, and key employees decide whether to stay. Each of these dynamics can cause a condition to fail — and each failure is an opportunity for the buyer to renegotiate, delay, or walk.

Regulatory Approvals: The Longest Pole in the Tent

Regulatory approval is usually the longest-running closing condition. For startup acquisitions in the United States, the most common regulatory gate is Hart-Scott-Rodino (HSR) Act premerger notification. If the transaction value exceeds the applicable threshold — $133.9 million for 2026, adjusted annually — both parties must file notification forms with the FTC and DOJ and observe a 30-day statutory waiting period before closing.

The waiting period can be extended significantly if the reviewing agency issues a "second request" for additional information, which can stretch the timeline to six months or more. For cross-border deals, foreign antitrust clearances and CFIUS national-security review may run in parallel — each with its own timeline and its own risk of delay or blockage.

How Regulatory Conditions Kill Deals

The regulatory condition becomes a deal-killer in two scenarios. First, the regulator blocks or conditions the transaction — requiring divestitures that gut the strategic rationale, or prohibiting the deal entirely. Second, the regulatory timeline exceeds the outside date (the "drop-dead date" after which either party can terminate), giving the buyer an easy exit without any affirmative obligation to push the deal through.

What Founders Must Negotiate

Three provisions are essential for protecting against regulatory failure:

• Efforts obligation: Require the buyer to use "commercially reasonable efforts" — or, in higher-risk deals, a "hell-or-highwater" clause committing the buyer to take any action necessary to obtain clearance, including divestitures and litigation. The Delaware Court of Chancery's decision in ChannelMedsystems v. Boston Scientific demonstrated that courts will enforce these obligations — Boston Scientific was ordered to specifically perform the merger after failing to use commercially reasonable efforts.
• Reverse termination fee: Negotiate a fee the buyer pays if the deal fails for regulatory reasons. For antitrust failure, these typically range from 3% to 8% of deal value. The Adobe-Figma breakup — in which Adobe paid Figma $1 billion when the deal was abandoned due to regulatory resistance — illustrates the scale of protection a well-negotiated RTF provides.
• Outside date calibration: Set the outside date long enough to accommodate the full regulatory timeline — at least 90 days for routine HSR filings, 12+ months for deals with significant antitrust risk. An outside date that is too short gives the buyer an escape hatch; one that is too long leaves you in indefinite limbo.

Third-Party Consents: The Silent Deal-Killers

Many of your company's most valuable contracts — customer agreements, commercial leases, debt facilities, intellectual property licenses, key vendor arrangements — contain change-of-control or assignment provisions that require counterparty consent before the contract can transfer to the acquirer. If consent is not obtained, the contract does not transfer, and the acquirer may be buying a business stripped of its most critical relationships.

The problem is timing. Third parties operate on their own schedules, not your deal timeline. A landlord may take 30 days to respond to a lease assignment request. A key customer may use the consent request as leverage to renegotiate pricing. A lender may demand repayment of the outstanding loan rather than consenting to the assumption. Each of these scenarios can cause a closing condition to fail — and each gives the buyer grounds to walk or renegotiate.

What Founders Must Negotiate

• Identify consents during diligence, not at signing. Before the definitive agreement is signed, inventory every material contract and identify which ones require consent for assignment or change-of-control. The purchase agreement should list these consents as specific closing conditions — and the parties should begin securing them immediately after signing.
• Negotiate a "commercially reasonable efforts" covenant. Both parties should covenant to use commercially reasonable efforts to obtain required consents, with specific timelines for each consent request.
• Address what happens if consent is denied. If a key customer or landlord refuses consent, the agreement should specify whether the deal proceeds without that contract (with a price adjustment), whether the seller retains the contract as a pass-through, or whether the failure of that specific consent constitutes a failure of the closing condition. Do not leave this to ambiguity.
• Push for a "best efforts" standard on critical consents. For contracts that are essential to the business — the top customer, the primary IP license, the main office lease — push for a "best efforts" or "reasonable best efforts" standard rather than the more lenient "commercially reasonable efforts."

Key Employee Retention: When People Walk, the Deal Walks

For startup acquisitions — especially acqui-hires and technology tuck-ins — the team is often the primary asset. Buyers frequently include a closing condition requiring that certain key employees remain employed through closing, or that those employees sign new employment agreements or retention agreements with the buyer as a condition of the transaction.

This condition creates a dangerous dynamic. Key employees learn about the acquisition and may begin interviewing elsewhere. They may resist signing new employment agreements with the buyer — particularly if the new agreements contain restrictive covenants or changed compensation terms. If a designated key employee declines to sign or departs before closing, the closing condition fails, and the buyer can walk — or use the failure as leverage to renegotiate the purchase price.

What Founders Must Negotiate

• Limit the key employee list. Push to keep the list of employees whose continued employment is a closing condition as short as possible — ideally limited to the founders and one or two truly irreplaceable engineers. The longer the list, the more failure points exist.
• Negotiate replacement rights. If a key employee departs before closing, the seller should have the right to substitute a replacement employee with comparable qualifications, rather than the condition automatically failing. This prevents a single departure from killing the entire deal.
• Structure retention bonuses before signing. Implement retention bonus arrangements with key employees before the deal is signed — not after. Once employees know the acquisition is pending, their leverage increases. A retention bonus that vests at closing (or 90 days post-closing) gives key employees a financial reason to stay through the transition.
• Resist "no-competes as closing conditions." Some buyers attempt to make the execution of non-compete agreements by key employees a closing condition. This is separate from the seller's own non-compete obligation. Push back — requiring every key engineer to sign a non-compete as a condition of closing creates an unnecessary failure point and imposes restrictions your team may not accept.

Bring-Down Certificates and No-MAC Certification

The bring-down is the closing condition that requires the seller's representations and warranties — the factual statements made at signing about the company's financial condition, contracts, IP, compliance, and operations — to remain accurate as of the closing date. Think of it as asking whether the snapshot taken at signing is still recognizable at closing.

As the Fenwick analysis of the landmark Akorn v. Fresenius decision explains, the bring-down operates separately from the standalone MAC clause. The bring-down asks: are the seller's signing-date statements still true today? The no-MAC condition asks: has the seller's business suffered a material adverse effect since signing? An acquirer can invoke either as a basis to walk — and conflating the two is a frequent trap.

The bring-down has two materiality standards, as standard M&A practice guides explain. Fundamental representations — corporate organization, authority, capitalization — must typically be "accurate in all respects" (or "in all but de minimis respects") as of closing. General business representations need only be "accurate in all material respects." The tougher standard for fundamental reps means that even minor inaccuracies in capitalization or corporate authority representations can prevent closing.

At closing, each side delivers an officer's certificate — a signed document attesting that its representations remain accurate as of the closing date, and that all closing conditions have been satisfied. This certificate is the formal mechanism through which the bring-down is certified. If the officer cannot in good faith sign the certificate, the condition fails.

What Founders Must Negotiate

• Push for "in all material respects" on as many reps as possible. The broader the "in all respects" standard, the more risk that a minor inaccuracy derails closing. Fundamental reps will get the tougher standard, but general business reps should carry the materiality qualifier.
• Negotiate MAE-qualified bring-down for regulatory and compliance reps. Instead of requiring that compliance reps be "accurate in all material respects," push for language requiring only that inaccuracies be ones that "would reasonably be expected to result in a material adverse effect." This is a higher bar for the buyer to invoke and was the standard the Akorn court analyzed.
• Understand the ordinary course covenant's interaction. Most agreements require the target to operate "in the ordinary course of business" between signing and closing. The Akorn court found that Akorn breached this covenant by failing to maintain FDA compliance systems. This is not merely a drafting concern — it means you must continue running the business properly during the gap period, not let deal distraction cause operational deterioration.
• Negotiate specific performance. If the buyer attempts to invoke a bring-down failure in bad faith, a specific performance remedy — allowing you to seek a court order compelling the buyer to close — is your most powerful defense. The ChannelMedsystems court granted specific performance against Boston Scientific. Without it, your primary remedy is damages, which may be inadequate.

Conditions Precedent and the Disproportionate Forfeiture Doctrine

A 2025 Delaware Supreme Court decision has added a new dimension to how closing conditions are interpreted. In Thompson Street Capital Partners IV, L.P. v. Sonova United States Hearing Instruments, LLC, the court adopted a framework from the Restatement (Second) of Contracts for determining when noncompliance with a condition precedent may be excused. As Mayer Brown's analysis of the decision explains, the framework asks (1) whether the agreement clearly and unambiguously triggers forfeiture of a contract right if the condition is not met, and (2) whether the potential forfeiture would be disproportionate compared to the harm to the other party if the condition were excused.

For founders, this ruling cuts both ways. It provides a potential defense if a minor, immaterial failure to satisfy a closing condition is being used to block the deal — a court may excuse the noncompliance if the forfeiture is disproportionate. But it also means that drafting matters enormously: conditions that are clearly stated as conditions precedent, with clearly defined consequences for failure, are more likely to be enforced strictly. Work with counsel to ensure that the closing conditions in your agreement are drafted with this framework in mind.

The Outside Date and Deal Drift

Every acquisition agreement should include an outside date — a drop-dead date after which either party can terminate the agreement if the closing conditions have not been satisfied. The outside date is the structural backstop against deal drift: the slow deterioration of deal momentum that occurs when closing conditions take longer than expected, the business operates in limbo, employees grow anxious, and the buyer's enthusiasm wanes.

The outside date interacts with every other closing condition. If regulatory review extends beyond the outside date, the deal terminates. If third-party consents are not obtained by the outside date, the deal terminates. If key employees depart before the outside date, the deal may terminate. The outside date is the clock that all other conditions run against.

What Founders Must Negotiate

• Set the outside date long enough to accommodate realistic timelines. A 60-day outside date is insufficient if HSR filing is required (30-day waiting period alone). Build in margin: 90 days for routine deals, 6-12 months for deals with regulatory complexity.
• Negotiate automatic extensions for regulatory delays. If the only remaining condition is regulatory approval and the parties are using commercially reasonable efforts to obtain it, the outside date should automatically extend — rather than allowing the buyer to walk simply because the regulator's clock ran longer than expected.
• Resist unilateral buyer extension rights. The buyer should not have the unilateral right to extend the outside date. Extensions should require mutual consent, or should be triggered only by specific defined events (e.g., second request issued).

Actionable Next Steps

1. Map every closing condition before signing the definitive agreement. List each condition, its owner, the estimated timeline for satisfaction, and the consequences if it fails. This map should be a negotiation tool — not a post-signing discovery exercise.
2. Negotiate efforts obligations and reverse termination fees for regulatory risk. If HSR or other regulatory approval is required, require the buyer to use commercially reasonable efforts (or hell-or-highwater for higher-risk deals) and negotiate a reverse termination fee sized to compensate for deal failure.
3. Inventory third-party consents during diligence. Identify every contract that requires consent for assignment or change-of-control. Begin securing consents immediately after signing. Address denied consents in the agreement with specific fallback provisions.
4. Structure key employee retention before signing. Implement retention bonuses for critical employees before the deal is announced. Keep the key employee list for closing conditions as short as possible, and negotiate replacement rights.
5. Scrutinize the bring-down standard. Push for "in all material respects" on general business reps. Negotiate MAE-qualified bring-down for compliance reps. Understand the difference between the bring-down and the standalone MAC clause — and negotiate both.
6. Calibrate the outside date to the deal's actual timeline. Build in margin for regulatory delays. Negotiate automatic extensions for regulatory-only conditions. Resist unilateral buyer extension rights.
7. Continue operating the business in the ordinary course. The Akorn decision demonstrates that failing to maintain operations properly between signing and closing can trigger both a MAC and a breach of the ordinary course covenant. Deal distraction is not a defense — it is a liability.
8. Engage experienced M&A counsel before signing. Closing conditions are not boilerplate. They are the gates between signing and closing — and the provisions that determine whether your signed deal actually becomes a closed deal. The cost of pre-signing negotiation of these conditions is trivial compared to the cost of a deal that dies in the signing-to-closing gap.

Signing is not closing. The founders who successfully navigate the signing-to-closing gap are the ones who mapped every closing condition before signing, negotiated efforts obligations and reverse termination fees, secured third-party consents early, retained key employees with financial incentives, and continued operating their business as if no acquisition were pending. The ones whose deals die in the gap are the ones who treated closing conditions as boilerplate — and discovered, too late, that boilerplate can kill a deal just as dead as a disputed valuation.